These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10878680)

  • 1. In obese individuals dexfenfluramine corrects molecular derangements reflecting insulin resistance.
    Piccinini M; Rabbone I; Novi RF; Alberto G; Mostert M; Musso A; Vai S; Gamba S; Rinaudo MT
    Int J Obes Relat Metab Disord; 2000 Jun; 24(6):735-41. PubMed ID: 10878680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in obese subjects and newly diagnosed NIDDM patients and derangements of pyruvate dehydrogenase in their circulating lymphocytes.
    Curto M; Novi RF; Rabbone I; Maurino M; Piccinini M; Mioletti S; Mostert M; Bruno R; Rinaudo MT
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1137-42. PubMed ID: 9426381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced blood insulin overcomes pyruvate dehydrogenase derangements that reflect systemic insulin resistance in obese adolescents.
    Mostert M; Cerutti F; Piccinini M; Rabbone I; Sacchetti C; Pacini G; Rinaudo MT
    Clin Sci (Lond); 2002 Jul; 103(1):93-9. PubMed ID: 12095410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular effects of sulphonylurea agents in circulating lymphocytes of patients with non-insulin-dependent diabetes mellitus.
    Rabbone I; Piccinini M; Curto M; Mostert M; Gamba S; Mioletti S; Bruno R; Rinaudo MT
    Br J Clin Pharmacol; 1998 Mar; 45(3):291-9. PubMed ID: 9517374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.
    Glaser B; Raveh Y; Norynberg C; Berry E; Lavielle R; Nathan C; Cerasi E
    Diabetes Res; 1992; 19(4):165-76. PubMed ID: 1343113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.
    Chow CC; Ko GT; Tsang LW; Yeung VT; Chan JC; Cockram CS
    Diabetes Care; 1997 Jul; 20(7):1122-7. PubMed ID: 9203448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.
    Koska J; Ortega E; Bunt JC; Gasser A; Impson J; Hanson RL; Forbes J; de Courten B; Krakoff J
    Diabetologia; 2009 Mar; 52(3):385-93. PubMed ID: 19104769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin signal and its effects on the pyruvate dehydrogenase complex in circulating lymphocytes of obese children.
    Curto M; Piccinini M; Cerutti F; Rabbone I; Mostert M; Sacchetti C; Bruno R; Rinaudo MT
    Int J Biochem; 1992 May; 24(5):831-7. PubMed ID: 1592161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte glycogen synthase and pyruvate dehydrogenase in obese and type II diabetic subjects.
    Mandarino LJ; Madar Z; Kolterman OG; Bell JM; Olefsky JM
    Am J Physiol; 1986 Oct; 251(4 Pt 1):E489-96. PubMed ID: 3094377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derangements of pyruvate dehydrogenase in circulating lymphocytes of NIDDM patients and their healthy offspring.
    Mostert M; Rabbone I; Piccinini M; Curto M; Vai S; Musso A; Rinaudo MT
    J Endocrinol Invest; 1999; 22(7):519-26. PubMed ID: 10475149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity.
    Yoshinaga H; Kosaka K
    Diabetes Res Clin Pract; 1999 May; 44(2):129-36. PubMed ID: 10414932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dexfenfluramine administration normalizes glucose tolerance in rats with insulin-deficient diabetes.
    Arora R; Dryden S; McKibbin PE; Williams G
    Eur J Clin Invest; 1994 Mar; 24(3):182-7. PubMed ID: 8033952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery.
    Polyzogopoulou EV; Kalfarentzos F; Vagenakis AG; Alexandrides TK
    Diabetes; 2003 May; 52(5):1098-103. PubMed ID: 12716738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females.
    Buffington CK; Givens JR; Kitabchi AE
    Diabetes; 1991 Jun; 40(6):693-700. PubMed ID: 1828239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
    J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of short-term dexfenfluramine therapy on glucose and lipid metabolism in obese non-diabetic patients.
    Andersen PH; Richelsen B; Bak J; Schmitz O; Sørensen NS; Lavielle R; Pedersen O
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):251-8. PubMed ID: 8480475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of pyruvate dehydrogenase phosphatase in obese subjects is a defect that signals insulin resistance.
    Piccinini M; Mostert M; Alberto G; Ramondetti C; Novi RF; Dalmasso P; Rinaudo MT
    Obes Res; 2005 Apr; 13(4):678-86. PubMed ID: 15897476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behaviour of pyruvate dehydrogenase in circulating lymphocytes from diabetic children.
    Rinaudo MT; Curto M; Bruno R; Marino C; Piccinini M; Cerutti F; Mostert M; Sacchetti C
    Diabetologia; 1989 Apr; 32(4):245-8. PubMed ID: 2668078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.